Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Energy flow is a fundamental biological and physical concept describing the movement and transformation of energy within living systems, rather than a specific molecular target such as a receptor, enzyme, or transporter (NCBI, 2023). In a cellular context, energy flow refers to bioenergetics—the set of metabolic pathways, including glycolysis, the citric acid cycle, and oxidative phosphorylation, that allow cells to convert nutrients into adenosine triphosphate (ATP) (Alberts B, et al., 2002). Because it represents a vast and integrated network of biochemical reactions involving hundreds of distinct proteins and metabolites, energy flow lacks the discrete biochemical structure or specific binding site required for classification as a therapeutic target. While specific components within this system, such as ATP synthase or AMP-activated protein kinase (AMPK), are legitimate drug targets, the overarching process of energy flow itself cannot be targeted by a single pharmacological agent (Berg JM, et al., 2002). Consequently, there are no drugs that interact with energy flow as a standalone entity, and it is considered an incorrect designation for a molecular target in drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Energy flow.